(USPH) US Physicalrapy - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US90337L1089
USPH: Physical, Therapy, Rehabilitation, Injury, Prevention, Services
U.S. Physical Therapy, Inc. is a leading provider of outpatient physical therapy services, operating a network of clinics across the United States. The company's operations are segmented into two main categories: Physical Therapy Operations and Industrial Injury Prevention Services. Through its Physical Therapy Operations segment, the company offers a range of services, including pre- and post-operative care, treatment for orthopedic-related disorders, sports-related injuries, preventative care, and rehabilitation for injured workers and individuals with neurological-related injuries. This comprehensive approach enables patients to receive personalized care and rehabilitation programs tailored to their specific needs.
The company's Industrial Injury Prevention Services segment is designed to help employers reduce workplace injuries and improve employee health. This is achieved through a variety of services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments. These services are delivered by experienced physical therapists and certified athletic trainers, who work closely with clients to develop and implement customized injury prevention and management programs. U.S. Physical Therapy, Inc.'s client base includes Fortune 500 companies, insurers, and their contractors, demonstrating the company's ability to provide high-quality services to a diverse range of organizations.
Founded in 1990 and headquartered in Houston, Texas, U.S. Physical Therapy, Inc. has established itself as a trusted provider of physical therapy services. With a strong commitment to delivering exceptional patient care and preventing workplace injuries, the company has built a reputation for excellence in the healthcare industry. As a publicly traded company listed on the New York Stock Exchange (NYSE) under the ticker symbol USPH, U.S. Physical Therapy, Inc. is subject to the highest standards of corporate governance and transparency. The company's website, https://www.usph.com, provides further information on its services, mission, and values. With an ISIN of US90337L1089 and classified under the GICS Sub Industry of Health Care Facilities, U.S. Physical Therapy, Inc. is a common stock that offers investors the opportunity to participate in the growth and development of the healthcare industry.
Additional Sources for USPH Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
USPH Stock Overview
Market Cap in USD | 1,372m |
Sector | Healthcare |
Industry | Medical Care Facilities |
GiC Sub-Industry | Health Care Facilities |
IPO / Inception | 1992-05-28 |
USPH Stock Ratings
Growth 5y | -21.3% |
Fundamental | 3.56% |
Dividend | 63.5% |
Rel. Strength Industry | -196 |
Analysts | 4.14/5 |
Fair Price Momentum | 82.14 USD |
Fair Price DCF | 123.78 USD |
USPH Dividends
Dividend Yield 12m | 1.95% |
Yield on Cost 5y | 1.62% |
Annual Growth 5y | 40.63% |
Payout Consistency | 92.0% |
USPH Growth Ratios
Growth Correlation 3m | 17.3% |
Growth Correlation 12m | -58.8% |
Growth Correlation 5y | -0.9% |
CAGR 5y | -3.69% |
CAGR/Mean DD 5y | -0.13 |
Sharpe Ratio 12m | -0.08 |
Alpha | -37.33 |
Beta | 1.35 |
Volatility | 32.90% |
Current Volume | 93.7k |
Average Volume 20d | 88.7k |
As of January 22, 2025, the stock is trading at USD 90.07 with a total of 93,741 shares traded.
Over the past week, the price has changed by +1.54%, over one month by +0.26%, over three months by +8.48% and over the past year by -3.22%.
Neither. Based on ValueRay Fundamental Analyses, US Physicalrapy is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 3.56 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of USPH as of January 2025 is 82.14. This means that USPH is currently overvalued and has a potential downside of -8.8%.
US Physicalrapy has received a consensus analysts rating of 4.14. Therefor, it is recommend to buy USPH.
- Strong Buy: 2
- Buy: 4
- Hold: 1
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, USPH US Physicalrapy will be worth about 91.5 in January 2026. The stock is currently trading at 90.07. This means that the stock has a potential upside of +1.55%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 111.3 | 23.6% |
Analysts Target Price | 124.8 | 38.5% |
ValueRay Target Price | 91.5 | 1.6% |